Episode

Staar Terminates Merger with Alcon

Podcast
Eyewire News: The Podcast
Published
Jan 7, 2026
Duration seconds
695
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/BMCL5468537677.mp3
Audio
https://traffic.megaphone.fm/BMCL5468537677.mp3
JSON
/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/staar-terminates-merger-with-alcon
Markdown
/podcast/eyewire-news-the-podcast-7055536/staar-terminates-merger-with-alcon.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/staar-terminates-merger-with-alcon/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/staar-terminates-merger-with-alcon.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Shareholders vote on Alcon’s blockbuster acquisition proposal for Staar Surgical; the FDA responds to Outlook’s latest BLA submission for wet AMD drug Lytenava; and the FDA approves an interchangeable biosimilar to Lucentis. Learn more about your ad choices. Visit megaphone.fm/adchoices